Processing 00000000.tx.1: Calpastatin Subdomains A and C Are Activators of Calpain* Peter Tompa, Zoltn Mucsi, Gyrgy Orosz, and Peter Friedrich From the Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, H-1518 Budapet, P.O.Box 7,and Research Group of Peptide Chemistry at Etvs Lornd University, Hungarian Academy of Sciences, Budapest, Hungary Received for publication, December 4,2001, and in revised form, January 22,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The inhibitory domains of calpastatin contain three highly conserved regions, A, B, and C, of which A and C bind calpain in a strictly Ca2+-dependent manner but have no inhibitory activity whereas region B inhibits calpain on its own. 

Phrase: "Calpastatin Subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "Are"

Phrase: "Activators of Calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   841   C0915424:calpain activator [Amino Acid, Peptide, or Protein]

Phrase: "* Peter Tompa,"

Phrase: "Zoltn Mucsi,"

Phrase: "Gyrgy Orosz,"

Phrase: "and"

Phrase: "Peter Friedrich From the Institute of Enzymology,"

Phrase: "Biological Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Hungarian Academy of Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000876:Academy [Organization]

Phrase: "H-1518 Budapet,"

Phrase: "P.O.Box 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0179400:Box [Manufactured Object]
   812   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1533124:Box [Medical Device]
   812   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Research Group of Peptide Chemistry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "at Etvs Lornd University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Hungarian Academy of Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000876:Academy [Organization]

Phrase: "Budapest,"

Phrase: "Hungary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020174:Hungary [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "December 4,"

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "January 22,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The inhibitory domains of calpastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three highly conserved regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "of which"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "calpain in a strictly Ca2+-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "have"

Phrase: "no inhibitory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "region B"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "calpain on its own."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.2: We synthesized the 19-mer oligopeptides corresponding to regions A and C of human calpastatin domain I and tested their effect on human erythrocyte -calpain and rat m-calpain. 

Phrase: "We"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "the 19-mer oligopeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028954:Oligopeptides [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "A"

Phrase: "and"

Phrase: "C of human calpastatin domain I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1547546:C-I [Classification]
   753   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "their effect on human erythrocyte -calpain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "m-"

Phrase: "calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.3: The two peptides significantly activate both calpains: the Ca2+ concentration required for half-maximal activity is lowered from 4.3to 2.4M for -calpain and from 250to 140M for m-calpain. 

Phrase: "The two peptides significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "both calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "the Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "required for half-maximal activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205177:Activity [Functional Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "is"

Phrase: "lowered from 4.3to 2.4M"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0441994:lowered [Spatial Concept]
   753   C1272755:Lowered [Quantitative Concept]
   753   C2003888:Lowered [Activity]
   719 E C1548802:Lower [Body Location or Region]

Phrase: "for -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and from 250to 140M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for"

Phrase: "m-"

Phrase: "calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.4: The EC50 concentration of the peptides is 7.5M for -calpain and 25M for m-calpain. 

Phrase: "The EC50 concentration of the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "7.5M for -calpain"

Phrase: "and"

Phrase: "25M for"

Phrase: "m-"

Phrase: "calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.5: It is noteworthy that at low Ca2+ concentrations (1-2 M for -calpain and 70-110 M for m-calpain) both enzymes are activated about 10-fold by the peptides. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that at low Ca2+ concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086045:Concentrations [Mental Process]
   760   C0205251:low [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1-2 M for -calpain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1120859:m-calpain [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "70-110 M for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "both enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "activated about 10-fold"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C1879547:Activated [Activity]
   770   C1880834:FOLD [Phenomenon or Process]
   737 E C1515877:Activate [Functional Concept]

Phrase: "by the peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.6: Based on these findings, it is suggested that calpastatin fragments may have a role in calpain activation in vivo. 

Phrase: "Based on these findings,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0243095:Finding [Finding]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2825141:Finding [Finding]

Phrase: "it"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calpastatin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a role in calpain activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.7: Furthermore, these activators open new avenues to cell biological studies of calpain function and eventually may alleviate pathological states caused by calpain malfunction.  

Phrase: "Furthermore,"

Phrase: "these activators"

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "new avenues to cell biological studies of calpain function"

Phrase: "and"

Phrase: "eventually"

Phrase: "may"

Phrase: "alleviate"

Phrase: "pathological states"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1301808:states [Geographic Area]
   861   C1521733:Pathological [Functional Concept]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]

Phrase: "caused by calpain malfunction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0231174:Malfunction [Functional Concept]
   770   C0277785:Malfunction, NOS [Qualitative Concept]
   770   C1881681:MALFUNCTION [Phenomenon or Process]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   715 E C0031847:dysfunction [Functional Concept]
Processing 00000000.tx.8: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Calpains represent a superfamily of proteases related by their homology in a papain-like protease domain (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a superfamily of proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883220:Superfamily [Conceptual Entity]

Phrase: "related by their homology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1334043:Homology [Gene or Genome]
   770   C2697616:Homology [Qualitative Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in a papain-like protease domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1514524:Protease Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.9: Several members of this family, such as the best studied typical forms, - and m-calpain, are thought to be activated by a Ca2+ signal; 

Phrase: "Several members of this family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "such as the best studied typical forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "-"

Phrase: "and"

Phrase: "m-"

Phrase: "calpain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated by a Ca2+ signal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1710082:Signal [Phenomenon or Process]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.10: their activation then leads to the limited proteolytic modification of a variety of substrate proteins. 

Phrase: "their activation then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "leads to the limited proteolytic modification of a variety of substrate proteins."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   736   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   736   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0181586:leads [Medical Device]
   736   C0392747:Modification [Functional Concept]
   736   C0439801:Limited [Functional Concept]
   736   C0597304:Proteolytic [Molecular Function]
   736   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   736   C1522538:Lead [Functional Concept]
   736   C1554963:modification [Qualitative Concept]
   736   C1710236:Substrate [Manufactured Object]
   736   C1883525:Variety [Conceptual Entity]
   736   C1947941:proteolytic [Enzyme]
   736   C2346866:Variety [Conceptual Entity]
   736   C2348269:Lead [Element, Ion, or Isotope]
   736   C3275067:LEAD [Therapeutic or Preventive Procedure]
   736   C3542948:Limited [Intellectual Product]
   734   C0033666:Protein Modification [Molecular Function]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   734   C2263112:protein modification [Molecular Function]
Processing 00000000.tx.11: Recent x-ray crystallographic studies of rat (3) and human (4) m-calpain have revealed the structural background of the Ca2+ dependence of calpain activity. 

Phrase: "Recent x-ray crystallographic studies of rat"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0034571:X-ray [Functional Concept]
   778   C0043299:X-ray, NOS [Diagnostic Procedure]
   778   C0043309:X-ray [Natural Phenomenon or Process]
   778   C0206755:Crystallography, X-Ray [Laboratory Procedure]
   778   C1306645:X-ray [Diagnostic Procedure]
   778   C1962945:X-ray [Diagnostic Procedure]
   748   C0086894:ray [Fish]
   748   C0851346:ray [Natural Phenomenon or Process]
   748   C0947630:studies [Laboratory Procedure]
   748   C2314876:ray [Fish]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(4"

Phrase: ")"

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the structural background of the Ca2+ dependence of calpain activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.12: Without Ca2+ the structure of the active site is distorted; 

Phrase: "Without Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "the structure of the active site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "distorted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700135:Distorted [Functional Concept]

Phrase: ";"
Processing 00000000.tx.13: large scale conformational changes have to occur for the assembly of a catalytically competent active site. 

Phrase: "large scale conformational changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C0301641:Conformational change [Molecular Function]
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur for the assembly of a catalytically competent active site."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205681:Active Site [Functional Concept]
   757   C2945843:Site of [Qualitative Concept]
   739   C0086035:Competent [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0205177:Active [Functional Concept]
   739   C1515974:Site [Body Location or Region]
   739   C1706853:Assembly [Activity]
   739   C1709305:Occur [Activity]
   739   C1879748:Assembly [Manufactured Object]
   739   C2745955:OCCUR [Temporal Concept]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.14: Although mechanistically clear, key aspects of the activation process in vivo are still enigmatic as calpains require non-physiologically high Ca2+ concentrations in vitro. 

Phrase: "Although"

Phrase: "mechanistically"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "key aspects of the activation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1547011:Aspect [Quantitative Concept]
   719   C1879746:Aspect [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "are"

Phrase: "still enigmatic as calpains"

Phrase: "require"

Phrase: "non-physiologically high Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.15: - and m-Calpains reach half-maximal activation in the high M to mM free Ca2+ concentration range (cf. Ref. 5), hardly attainable under normal cellular conditions. 

Phrase: "-"

Phrase: "and"

Phrase: "m-"

Phrase: "Calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "half-maximal activation in the high M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "to mM free Ca2+ concentration range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: "(cf. Ref. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "hardly attainable under normal cellular conditions."
Processing 00000000.tx.16: Several suggestions have been put forward on how to close this gap. 

Phrase: "Several suggestions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038659:Suggestions [Idea or Concept]
   827 E C1705535:suggestion [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "put"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882509:Put [Activity]

Phrase: "forward on how to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439780:Forward [Spatial Concept]

Phrase: "close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "this gap."
Processing 00000000.tx.17: First, calpain undergoes autolytic activation with a concomitant sensitization to Ca2+ (5, 6); 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "undergoes"

Phrase: "autolytic activation with a concomitant sensitization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "to Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.18: this, of course, does not alleviate the initial high Ca2+ requirement. 

Phrase: "this,"

Phrase: "of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alleviate"

Phrase: "the initial high Ca2+ requirement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.19: Second, phospholipids increase calcium sensitivity of calpain (7, 8), and activation probably involves the translocation of the enzyme to the plasma membrane (9, 10). 

Phrase: "Second, phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calcium sensitivity of calpain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "activation probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "involves"

Phrase: "the translocation of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.20: Third, calpain might also be sensitized to Ca2+ by a specific activator protein that affects membrane localization and autolysis of the enzyme (11). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "sensitized to Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "by a specific activator protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "membrane localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "autolysis of the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004372:Autolysis [Pathologic Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: Nuclear DNA, shown to promote calpain effect on transcription factors and other nuclear proteins, may be another positive effector (12). 

Phrase: "Nuclear DNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "calpain effect on transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "other nuclear proteins,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "another positive effector"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.22: The above factors have been characterized to different extents, and there is no consensus with respect to their contribution. 

Phrase: "The above factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "characterized to different extents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439792:Extents [Spatial Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "no consensus with respect to their contribution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0376298:Consensus [Social Behavior]
Processing 00000000.tx.23: In this paper we raise the possibility of an additional, rather unexpected mode of calpain sensitization to Ca2+ by fragments of its endogenous inhibitor, calpastatin. 

Phrase: "In this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "raise"

Phrase: "the possibility of an additional, rather unexpected mode of calpain sensitization"

Phrase: "to Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "by fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "of its endogenous inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205227:Endogenous [Functional Concept]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "calpastatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]
Processing 00000000.tx.24: Typical calpastatin molecules have five structural domains; 

Phrase: "Typical calpastatin molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "have"

Phrase: "five structural domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.25: the function of the N-terminal domain is not clear, the other four homologous domains are all capable of inhibiting a calpain molecule (13, 14). 

Phrase: "the function of the N-terminal domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "the"

Phrase: "other four homologous domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "all capable of inhibiting"

Phrase: "a calpain molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: The presence of Ca2+ is mandatory for calpain binding and inhibition by calpastatin (15-17), and calpastatin binding invariably occurs at a Ca2+ concentration significantly lower than that needed for enzyme activity (18). 

Phrase: "The presence of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "mandatory for calpain binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514873:Mandatory [Functional Concept]
   770   C1554132:Mandatory [Idea or Concept]
   770   C1619643:Mandatory [Idea or Concept]

Phrase: "and"

Phrase: "inhibition by calpastatin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(15-17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "invariably"

Phrase: "occurs at a Ca2+ concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086045:Concentration [Mental Process]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "significantly lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "needed for enzyme activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0243102:enzyme activity [Molecular Function]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0027552:Needed [Qualitative Concept]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0686904:needed [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.27: Each inhibitory domain contains three short conserved stretches of about 20amino acids, termed subdomains A, B, and C (cf. Fig. 1). 

Phrase: "Each inhibitory domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three short conserved stretches of about 20amino acids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0270814:Stretches [Disease or Syndrome]
   711 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "subdomains"

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C (cf. Fig. 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1418485:C-1 [Gene or Genome]
   875   C0055412:CF 1 [Organic Chemical,Pharmacologic Substance]
   875   C2698722:CF-1 [Mammal]
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.28: In functional studies it was shown that subdomain B is responsible for inhibition (19-21), whereas subdomains A and C potentiate this inhibitory effect by binding to the calmodulin-like domains of the large and small subunit, respectively, in a strictly Ca2+-dependent manner (17, 20-22). 

Phrase: "In functional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that subdomain B is"

Phrase: "responsible for inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "(19-21"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "potentiate"

Phrase: "this inhibitory effect by binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "to the calmodulin-like domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "of the large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "small subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0700321:Small [Quantitative Concept]
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "respectively,"

Phrase: "in a strictly Ca2+-dependent manner"

Phrase: "(17,"

Phrase: "20-22"

Phrase: ")."
Processing 00000000.tx.29: Subdomains A and C have no inhibitory effect on calpain (20-23). 

Phrase: "Subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "have"

Phrase: "no inhibitory effect on calpain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(20-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: View larger version (43K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.31: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.32: Alignment of human calpastatin inhibitory domains. 

Phrase: "Alignment of human calpastatin inhibitory domains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1706765:Alignment [Quantitative Concept]
Processing 00000000.tx.33: The four domains of human calpastatin inhibitory to calpain are shown aligned. 

Phrase: "The four domains of human calpastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "inhibitory to calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3463820:Inhibitory [Activity]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "aligned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706765:Aligned [Quantitative Concept]
   966 E C2369992:Align [Pharmacologic Substance]
Processing 00000000.tx.34: Identity or strong similarity of residues extending to four (black) or three (gray) domains are marked by shading. 

Phrase: "Identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "or"

Phrase: "strong similarity of residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similarity [Qualitative Concept]

Phrase: "extending to four"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205450:Four [Quantitative Concept]
   790   C0439792:Extending [Spatial Concept]
   756 E C0231448:Extend [Functional Concept]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "marked by shading."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.35: Subdomains A, B, and C, as defined in Ref. 

Phrase: "Subdomains"

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "as"

Phrase: "defined in Ref."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1425988:REF [Gene or Genome]
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.36: 21, are boxed. 

Phrase: "21,"

Phrase: "are"

Phrase: "boxed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]
Processing 00000000.tx.37: These observations allow for a very intriguing possibility, the activation of calpain by calpastatin fragments. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "allow for a very"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442824:Very [Qualitative Concept]
   770   C0683607:allow [Social Behavior]

Phrase: "intriguing"

Phrase: "possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "the activation of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by calpastatin fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.38: Namely, as binding of calpastatin and its subdomains to calpain is facilitated by Ca2+, thermodynamic necessity demands that the reverse be also true: calpastatin should facilitate Ca2+ binding to calpain. 

Phrase: "Namely,"

Phrase: "as"

Phrase: "binding of calpastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "its subdomains to calpain"

Phrase: "is"

Phrase: "facilitated by Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "thermodynamic necessity"

Phrase: "demands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441516:Demand [Therapeutic or Preventive Procedure]
  1000   C0699784:demand [Idea or Concept]

Phrase: "that"

Phrase: "the reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "be"

Phrase: "also true"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205238:True [Qualitative Concept]

Phrase: ":"

Phrase: "calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "should"

Phrase: "facilitate"

Phrase: "Ca2+ binding to calpain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
Processing 00000000.tx.39: In other words, calpastatin or its subdomains must lower the Ca2+ demand of calpain. 

Phrase: "In other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "or"

Phrase: "its subdomains"

Phrase: "must"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the Ca2+ demand of calpain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441516:Demand [Therapeutic or Preventive Procedure]
   760   C0699784:demand [Idea or Concept]
Processing 00000000.tx.40: This is clearly seen with whole calpastatin, which binds at a Ca2+ concentration significantly lower than that needed for calpain activity (18). 

Phrase: "This"

Phrase: "is"

Phrase: "clearly"

Phrase: "seen with whole calpastatin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0444667:Whole [Quantitative Concept]
   770   C1413137:CALPASTATIN [Gene or Genome]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "which"

Phrase: "binds at a Ca2+ concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086045:Concentration [Mental Process]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "significantly lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "needed for calpain activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1150129:calpain activity [Molecular Function]
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0027552:Needed [Qualitative Concept]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0686904:needed [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.41: In essence, calpastatin shifts the conformational equilibrium of calpain toward the active form; 

Phrase: "In essence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028910:Essence [Organic Chemical]
   928 E C0205224:Essential [Qualitative Concept]

Phrase: "calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the conformational equilibrium of calpain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "toward the active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.42: activation with whole calpastatin, of course, is not seen because of blocking of the active site by subdomain B.

Phrase: "activation with whole calpastatin, of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen because of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "blocking of the active site"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C0205681:Active Site [Functional Concept]
   797   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "by subdomain B."
Processing 00000000.tx.43: Subdomains A and C, on the other hand, lack this inhibitory potential. 

Phrase: "Subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C,"

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "this inhibitory potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0234122:Inhibitory potential [Organ or Tissue Function]
   861   C3245505:Potential [Qualitative Concept]
   861   C3463820:Inhibitory [Activity]
Processing 00000000.tx.44: In earlier experiments they did not inhibit calpain at high Ca2+ concentrations (20-23). 

Phrase: "In earlier experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "calpain at high Ca2+ concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(20-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: Our results here show that they in fact potentiate Ca2+ binding and thus activate the enzyme at subsaturating Ca2+ levels.  

Phrase: "Our results here"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "they in fact"

Phrase: "potentiate"

Phrase: "Ca2+ binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "thus"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the enzyme at subsaturating Ca2+ levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0014440:enzyme levels [Laboratory Procedure]
   783   C1287349:enzyme levels [Laboratory or Test Result]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.46: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Enzymes-- Human erythrocyte -calpain was purchased from Calbiochem (catalog no. 208713). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "--"

Phrase: "Human erythrocyte -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(catalog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376658:Catalog [Intellectual Product]

Phrase: "no. 208713"

Phrase: ")."
Processing 00000000.tx.47: Rat m-calpain composed of an 80-kDa large subunit and a 21-kDa truncated small subunit was expressed in Escherichia coli and purified via the C-terminal His tag attached to its large subunit as given in Ref. 

Phrase: "Rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "composed of an 80-kDa large subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0549177:Large [Quantitative Concept]
   748   C1532717:kDa [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "a 21-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "truncated"

Phrase: "small subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0700321:Small [Quantitative Concept]
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "expressed in Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014834:Escherichia coli [Bacterium]
   770   C0014833:Escherichia [Bacterium]

Phrase: "and"

Phrase: "purified via the C-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1707271:C-Terminal [Amino Acid Sequence]
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "His tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037293:Tag [Neoplastic Process]
  1000   C0181496:Tag [Manufactured Object]
  1000   C1710492:TAG [Gene or Genome]

Phrase: "attached to its large subunit"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0231441:Attached [Finding]
   760   C0549177:Large [Quantitative Concept]
   760   C1711351:Subunit [Quantitative Concept]
   726 E C1314972:ATTACH [Intellectual Product]

Phrase: "as"

Phrase: "given in Ref."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1425988:REF [Gene or Genome]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]
Processing 00000000.tx.48: 24. 

Phrase: "24."
Processing 00000000.tx.49: The enzymes were dialyzed against three changes of 10mM HEPES, 150mM NaCl, 1mM EDTA, 2mM benzamidine, 0.2mM phenylmethylsulfonyl fluoride, and 15mM -mercaptoethanol (calpain buffer) and stored at 4C until use. 

Phrase: "The enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "dialyzed against three changes of 10mM HEPES,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0205449:Three [Quantitative Concept]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "2mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "0.2mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "15mM -mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "(calpain buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "stored at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C1698986:Store [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: On the day of use a small aliquot was taken out and reactivated with 15mM -mercaptoethanol for 1h prior to the experiments. 

Phrase: "On the day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "of"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "a small aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "reactivated with 15mM -mercaptoethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025402:Mercaptoethanol [Organic Chemical]
   770   C0521123:Reactivated [Functional Concept]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "prior to the experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.51: Peptides-- The acetylated oligopeptide amides used in the present study correspond to subdomains A and C of human calpastatin inhibitory domain I (cf. Fig. 1 and Ref. 21) and have the sequence as follows. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "-"

Phrase: "-"

Phrase: "The acetylated oligopeptide amides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002482:Amides [Organic Chemical]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "correspond"

Phrase: "to subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C of human calpastatin inhibitory domain I (cf. Fig. 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1418485:C-1 [Gene or Genome]
   757   C1547546:C-I [Classification]
   739   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Ref. 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "have"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.52: A, SGKSGMDAALDDLIDTLGG; 

Phrase: "A,"

Phrase: "SGKSGMDAALDDLIDTLGG"

Phrase: ";"
Processing 00000000.tx.53: C, SKPIGPDDAIDALSSDFTS. 

Phrase: "C,"

Phrase: "SKPIGPDDAIDALSSDFTS."
Processing 00000000.tx.54: The peptides were synthesized on 4-methylbenzhydrylamine resin by solid phase method using the Boc1 technique. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "synthesized on 4-methylbenzhydrylamine resin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035191:Resin [Biomedical or Dental Material]
   760   C1883254:Synthesized [Activity]

Phrase: "by solid phase method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Boc1 technique."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.55: The side protection groups were as follows: Boc-Asp(cHex), Boc-Lys(2-Cl-Z), Boc-Ser(Bzl), Boc-Thr(Bzl). 

Phrase: "The side protection groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1709737:Protection Group [Conceptual Entity]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Boc-Asp(cHex"

Phrase: ")"

Phrase: ","

Phrase: "Boc-Lys(2-Cl-Z"

Phrase: ")"

Phrase: ","

Phrase: "Boc-Ser(Bzl"

Phrase: ")"

Phrase: ","

Phrase: "Boc-Thr(Bzl"

Phrase: ")."
Processing 00000000.tx.56: All Boc derivatives were obtained from Reanal, Budapest, Hungary. 

Phrase: "All Boc derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "obtained from Reanal,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "Budapest,"

Phrase: "Hungary."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020174:Hungary [Geographic Area]
Processing 00000000.tx.57: The coupling was carried out by using 2eq of protected amino acid derivative and 1.9eq of O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate (dissolved in 1-methyl-2-pyrrolidone or in N,N-dimethylformamide), in the presence of N,N-diisopropylethylamine for 30min. 

Phrase: "The coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439787:Out [Spatial Concept]
   833   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2eq of protected amino acid derivative"

Phrase: "and"

Phrase: "1.9eq"

Phrase: "of O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate"

Phrase: "("

Phrase: "dissolved in 1-methyl-2-pyrrolidone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0044438:Methyl Pyrrolidone [Organic Chemical,Pharmacologic Substance]
   753   C0034328:pyrrolidone [Organic Chemical]
   753   C0046547:pyrrolidone [Organic Chemical]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "or in N,N-dimethylformamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012426:Dimethylformamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of N,N-diisopropylethylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0067365:N,N-diisopropylethylamine [Organic Chemical]

Phrase: "for 30min."
Processing 00000000.tx.58: In case of positive ninhydrin assay the coupling was repeated until no free amino groups were detected. 

Phrase: "In case of positive ninhydrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028098:Ninhydrin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "the coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]

Phrase: "was"

Phrase: "repeated until no free amino groups"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   756   C0596072:amino group [Inorganic Chemical]
   753   C0205341:Repeated [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C1547730:Repeat [Temporal Concept]
   719 E C1705914:Repeat [Conceptual Entity]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.59: The Boc group was cleaved by 100% trifluoroacetic acid for 11min. 

Phrase: "The Boc group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0075733:BOC group [Organic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "cleaved by 100% trifluoroacetic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0040982:Trifluoroacetic Acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "for 11min."
Processing 00000000.tx.60: After the cleavage the resin was washed with 5% N,N-diisopropylethylamine in dichloromethane and with dichloromethane. 

Phrase: "After the cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "the resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035191:Resin [Biomedical or Dental Material]

Phrase: "was"

Phrase: "washed with 5% N,N-diisopropylethylamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1548982:Washed [Idea or Concept]
   719 E C0441648:Wash [Activity]

Phrase: "in dichloromethane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025748:Dichloromethane [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and with dichloromethane."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0025748:Dichloromethane [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.61: The N-terminal aminoacetyl group was introduced by reacting the resin-bound peptide with 10eq of 4-nitrophenyl acetate. 

Phrase: "The N-terminal aminoacetyl group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "introduced by reacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1292748:introduce [Functional Concept]

Phrase: "the resin-bound peptide with 10eq of 4-nitrophenyl acetate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.62: The peptides were cleaved from the resin by liquid HF (20ml) at 5C, in the presence of 2ml of anisole and 100mg of dithiothreitol for 1.5h. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "cleaved from the resin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035191:Resin [Biomedical or Dental Material]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "by liquid HF (20ml"

Phrase: ")"

Phrase: "at 5C,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2ml"

Phrase: "of anisole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051922:anisol [Organic Chemical]

Phrase: "and"

Phrase: "100mg of dithiothreitol"

Phrase: "for 1.5h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979835:1.5H [Temporal Concept]
   861   C1442467:5H [Temporal Concept]
Processing 00000000.tx.63: The peptides were purified by gel filtration in 30% acetic acid followed by reverse phase-high performance liquid chromatography on a Vydac 5-m C18 column (2504.6mm) (Hesperia, CA) using 0.045% trifluoroacetic acid in water as eluent A, 0.036% trifluoroacetic acid in acetonitrile as eluent B, and linear gradient 30-55% B in 60min and 20-52% B in 30min for peptide A or 8.5-30% B in 100min and 5-40% B in 30min for peptide C.

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "purified by gel filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008559:Gel Filtration [Laboratory Procedure]
   770   C0016107:filtration [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "in 30% acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "followed by reverse phase-high performance liquid chromatography"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C2700149:HIGH [Intellectual Product]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "on a Vydac 5-m C18 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "(2504.6mm"

Phrase: ")"

Phrase: "(Hesperia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1485169:Hesperia [Eukaryote]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.045% trifluoroacetic acid in water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "as eluent A,"

Phrase: "0.036% trifluoroacetic acid in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "as eluent B,"

Phrase: "and"

Phrase: "linear gradient 30-55% B in 60min"

Phrase: "and"

Phrase: "20-52% B in 30min"

Phrase: "for peptide A"

Phrase: "or"

Phrase: "8.5-30% B in 100min"

Phrase: "and"

Phrase: "5-40% B in 30min"

Phrase: "for peptide C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071642:peptide C [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.64: The homogeneity of peptide A was >98% and of peptide C was >92%. 

Phrase: "The homogeneity of peptide A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881065:Homogeneity [Qualitative Concept]

Phrase: "was >"

Phrase: "98%"

Phrase: "and of peptide C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C1515981:And [Idea or Concept]

Phrase: "was >"

Phrase: "92%."
Processing 00000000.tx.65: The peptides were checked by amino acid analysis using a Beckman model 6300amino acid analyzer, and mass spectra were recorded on a PerkinElmer Sciex API2000 triple quadrupole instrument (Toronto, Canada) equipped with TurboIonspray source. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "checked by amino acid analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1283174:Checked [Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Beckman model 6300amino acid analyzer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0179038:Analyzer [Medical Device]
   804   C1706246:Analyzer [Manufactured Object]

Phrase: "and"

Phrase: "mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0037813:Mass Spectrum [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded on a PerkinElmer Sciex API2000 triple quadrupole instrument"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205174:Triple [Quantitative Concept]
   742   C0348000:Instrument [Medical Device]
   742   C2347727:Quadrupole [Research Device]
   708   C0034869:Record [Intellectual Product]

Phrase: "(Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "equipped with TurboIonspray source."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]
Processing 00000000.tx.66: Both peptides were dissolved in calpain buffer at 5mg/ml concentration and stored in aliquots at 20C until use. 

Phrase: "Both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "dissolved in calpain buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "at 5mg/ml concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "stored in aliquots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1510844:Aliquot [Quantitative Concept]
   756   C1698986:Store [Functional Concept]

Phrase: "at 20C"

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.67: Calpain Activity Measurements-- Calpain activity was measured in a Jasco FP 777spectrofluorometer at excitation and emission wavelengths of 380and 460nm in a 33mm quartz cuvette. 

Phrase: "Calpain Activity Measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:measurements [Functional Concept]
   734   C1150129:calpain activity [Molecular Function]

Phrase: "--"

Phrase: "Calpain activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured in a Jasco FP 777spectrofluorometer"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0444706:Measured [Qualitative Concept]
   753   C1419068:FP [Gene or Genome]
   753   C1419906:FP [Gene or Genome]
   753   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3541412:FP [Gene or Genome]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "at excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths of 380and 460nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449819:wavelengths [Quantitative Concept]

Phrase: "in a 33mm quartz cuvette."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0180266:cuvette [Medical Device]
Processing 00000000.tx.68: The reaction mixture in 50l of calpain buffer contained 1mM LY-AMC as substrate at various peptide and Ca2+ concentrations as indicated. 

Phrase: "The reaction mixture in 50l of calpain buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439962:Mixture [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "1mM LY-AMC as substrate"

Phrase: "at various peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.69: The actual free Ca2+ concentration was calculated from the total concentrations by using the stability constant log Kapp=7.815for Ca2+-EDTA. 

Phrase: "The actual free Ca2+ concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0086045:Concentration [Mental Process]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "calculated from the total concentrations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0086045:Concentrations [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the stability constant log Kapp"

Phrase: "=7.815for Ca2+-EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.70: The reaction was started by the rapid mixing of the enzyme at a final concentration of 0.1M. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by the rapid mixing of the enzyme"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205430:mixing [Functional Concept]
   744   C0439831:Rapid [Qualitative Concept]
   744   C1272689:Started [Qualitative Concept]
   711 E C0439659:Start [Temporal Concept]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.1M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]
Processing 00000000.tx.71: The fluorescent trace recorded was transferred to a PC and evaluated by the MicroCal Origin data analysis software for determining the initial slope of fluorescence change; 

Phrase: "The fluorescent trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "was"

Phrase: "transferred to a PC"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0348011:transferred [Functional Concept]
   770   C3540812:PC [Gene or Genome]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "evaluated by the MicroCal Origin data analysis software"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0010992:Data Analysis [Occupational Activity]
   767   C3641102:Data Origin [Idea or Concept]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0037585:Software [Intellectual Product,Manufactured Object]
   744   C0079946:origin [Classification]
   744   C0220825:Evaluated [Functional Concept]
   744   C0439659:Origin [Temporal Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1511726:Data [Idea or Concept]
   744   C1524024:analysis [Functional Concept]
   744   C1550512:origin [Intellectual Product]
   744   C3245479:data [Medical Device]
   739   C0679560:genetic analysis [Laboratory Procedure]
   739   C0796344:Genetic Analysis [Laboratory Procedure]

Phrase: "for determining"

Phrase: "the initial slope of fluorescence change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0807955:Slope [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.72: it was checked that this slope was proportional to enzyme amount/activity under the given conditions. 

Phrase: "it"

Phrase: "was"

Phrase: "checked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Checked [Activity]

Phrase: "that"

Phrase: "this slope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0807955:Slope [Quantitative Concept]

Phrase: "was"

Phrase: "proportional to enzyme amount/activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205351:Proportional [Qualitative Concept]

Phrase: "under the given conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.73: Materials-- The fluorescent substrate LY-AMC (catalog no. S 1153) and all other chemicals were purchased from Sigma. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The fluorescent substrate LY-AMC (catalog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0376658:Catalog [Intellectual Product]

Phrase: "no. S 1153"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0755617:S 1153 [Organic Chemical,Pharmacologic Substance]
   861   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "all other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.74: The buffer was prepared with ion-exchanged distilled water.  

Phrase: "The buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "prepared with ion-exchanged distilled water."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   773   C0022013:Ion Exchange [Molecular Function]
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0599638:WATER [Substance]
   753   C0681549:distilled [Occupational Activity]
   753   C1550678:Water [Inorganic Chemical]
   753   C1700702:ION [Functional Concept]
   719   C0678640:exchange [Social Behavior]
   719   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.75: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES To see if oligopeptides A and C have an effect on -calpain activity, an intermediate Ca2+ concentration was used at which the enzyme activity could be conveniently measured but was significantly lower than that at saturating Ca2+ concentrations (13% at 2.4M free Ca2+). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "if"

Phrase: "oligopeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028954:Oligopeptides [Amino Acid, Peptide, or Protein]

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "have"

Phrase: "an effect on -calpain activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150129:calpain activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "an intermediate Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "used at which"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "conveniently"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "but"

Phrase: "was"

Phrase: "significantly lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "at saturating Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(13% at 2.4M free Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.76: At this Ca2+ level the enzyme was titrated with increasing concentrations of a mixture of peptides A+C.

Phrase: "At this Ca2+ level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "titrated with increasing concentrations of a mixture of peptides"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   742   C0086045:Concentrations [Mental Process]
   742   C0439962:Mixture [Substance]
   742   C0442808:Increasing [Functional Concept]
   708 E C1446561:Concentration [Quantitative Concept]
   708   C1883350:Titrate [Health Care Activity]

Phrase: "A+C."
Processing 00000000.tx.77: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.78: 2 shows that the oligopeptides increase calpain activity about 5-fold with an EC50 concentration around 7.5M. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the oligopeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028954:Oligopeptides [Amino Acid, Peptide, or Protein]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calpain activity about 5-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150129:calpain activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "with an EC50 concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "around 7.5M."
Processing 00000000.tx.79: The concentration dependence of activation has a slight sigmoidal shape, which hints at a cooperative effect between the two peptides. 

Phrase: "The concentration dependence of activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "has"

Phrase: "a slight sigmoidal shape,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332479:Shape [Spatial Concept]
   827   C0348078:shape [Qualitative Concept]
   827   C0522512:Shape [Spatial Concept]

Phrase: "which"

Phrase: "hints at a cooperative effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0679729:cooperative [Organization]
   760   C1280500:Effect [Qualitative Concept]
   760   C1415545:HINT [Gene or Genome]
   760   C1512348:HINTS [Intellectual Product]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "between the two peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.80: Subdomains A and C, when applied separately, also activate the enzyme (Fig. 2). 

Phrase: "Subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C,"

Phrase: "when"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "separately,"

Phrase: "also"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: Under the conditions used both increase the activity about 2-3-fold, with a half-maximal effect around 15M concentration. 

Phrase: "Under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the activity about 2-3-fold,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "with a half-maximal effect"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0205289:Maximal [Qualitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "around 15M concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.82: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.84: Activation of human -calpain by calpastatin subdomains A and C.

Phrase: "Activation of human -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by calpastatin subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.85: The activity of -calpain was measured by a fluorescent peptide substrate, LY-AMC, at 2.4M free Ca2+ concentration as given under "Experimental Procedures." 

Phrase: "The activity of -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured by a fluorescent peptide substrate,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0444706:Measured [Qualitative Concept]
   753   C1710236:Substrate [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "LY-AMC,"

Phrase: "at 2.4M free Ca2+ concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0086045:Concentration [Mental Process]
   799   C0332296:free [Functional Concept]
   799   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1446561:Concentration [Quantitative Concept]
   799   C1880497:Free [Qualitative Concept]
   799   C1996904:Free [Qualitative Concept]
   727 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "given under ""Experimental Procedures."""
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1550718:given [Idea or Concept]
   770   C2700391:procedures [Activity]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.86: To the assay, either peptide A () or C () or both A and C () were added at the concentrations indicated. 

Phrase: "To the assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "either peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "A ()"

Phrase: "or"

Phrase: "C ()"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "both A"

Phrase: "and"

Phrase: "C ()"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "added at the concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1524062:Added [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.87: The initial rate of substrate consumption was determined and plotted in percentage of the activity measured at saturating (2mM) Ca2+ concentration. 

Phrase: "The initial rate of substrate consumption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205265:Initial [Temporal Concept]
   753   C0871208:Rate [Activity]
   753   C1279901:Initial [Qualitative Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "and"

Phrase: "plotted in percentage of the activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "measured at saturating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0522534:saturating [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(2mM"

Phrase: ")"

Phrase: "Ca2+ concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.88: Data points represent the mean of three separate experiments. 

Phrase: "Data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean of three separate experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.89: Activation of calpain at subsaturating Ca2+ concentration might result from the expected sensitization to Ca2+, from a net increase in maximal activity without affecting Ca2+ sensitivity, or both. 

Phrase: "Activation of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "at subsaturating Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "might"

Phrase: "result from the expected sensitization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1274040:Result [Functional Concept]
   760   C1325847:Sensitisation [Mental Process]
   760   C1517001:Expected [Idea or Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "to Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from a net increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in maximal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "without affecting Ca2+ sensitivity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.90: To distinguish between these alternatives, the Ca2+ dependence of -calpain in the absence of peptides and in the presence of peptides at saturating concentration (40M each) was measured (Fig. 3A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between these alternatives,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1523987:Alternative [Conceptual Entity]

Phrase: "the Ca2+ dependence of -calpain in the absence of peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and in the presence of peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]

Phrase: "at saturating concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(40M"

Phrase: "each"

Phrase: ")"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.91: Activation is clearly due to a significant increase in Ca2+ sensitivity of the enzyme, the concentration of half-maximal activity shifts from 4.3to 2.4M upon the addition of the peptide mixture. 

Phrase: "Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "clearly due to a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0237881:significant [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "in Ca2+ sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "of the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "the concentration of half-maximal activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
   748   C2347813:Concentration Maximum [Quantitative Concept]

Phrase: "shifts from 4.3to 2.4M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "upon the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of the peptide mixture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]
Processing 00000000.tx.92: The maximal activity at saturating Ca2+ concentrations, on the other hand, is unchanged within experimental error. 

Phrase: "The maximal activity at saturating Ca2+ concentrations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "is"

Phrase: "unchanged within experimental error."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442739:Unchanged [Finding]
   770   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.93: With respect to the physiological activation of the enzyme, it is potentially very significant that an activation of about an order of magnitude is seen at low Ca2+ concentrations (Fig. 3B). 

Phrase: "With respect to the physiological activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "potentially very significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0237881:significant [Quantitative Concept]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "that"

Phrase: "an activation of about"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "an order of magnitude"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "is"

Phrase: "seen at low Ca2+ concentrations"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0086045:Concentrations [Mental Process]
   760   C0205251:low [Qualitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0042789:see [Organism Function]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1947903:See [Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.94: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.96: Ca2+ dependence of human -calpain activation by calpastatin subdomains A and C.A, the activity of -calpain was measured by LY-AMC at the free Ca2+ concentrations indicated in the absence () or presence () of 40M peptides A and C.

Phrase: "Ca2+ dependence of human -calpain activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "by calpastatin subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C."

Phrase: "A,"

Phrase: "the activity of -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured by LY-AMC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0023634:LY [Geographic Area]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "at the free Ca2+ concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0086045:Concentrations [Mental Process]
   827   C0332296:free [Functional Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "indicated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of 40M peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.97: The initial rate of substrate consumption was determined and plotted in percentage of the activity measured at saturating (2mM) Ca2+ concentration. 

Phrase: "The initial rate of substrate consumption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205265:Initial [Temporal Concept]
   753   C0871208:Rate [Activity]
   753   C1279901:Initial [Qualitative Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "and"

Phrase: "plotted in percentage of the activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "measured at saturating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0522534:saturating [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(2mM"

Phrase: ")"

Phrase: "Ca2+ concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.98: Data points represent the meanS.D. for three or four separate measurements. 

Phrase: "Data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.D."

Phrase: "for three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "or"

Phrase: "four separate measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]
Processing 00000000.tx.99: Free Ca2+ concentration needed for half-maximal activation is shifted from 4.3to 2.4M by the peptides. 

Phrase: "Free Ca2+ concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0086045:Concentration [Mental Process]
   827   C0332296:free [Functional Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for half-maximal activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0027552:Needed [Qualitative Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0686904:needed [Functional Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1879547:Activation [Activity]
   760   C2825407:Half [Quantitative Concept]

Phrase: "is"

Phrase: "shifted from 4.3to 2.4M"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0333051:shifted [Functional Concept]
   719 E C2347509:Shift [Phenomenon or Process]

Phrase: "by the peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.100: B, the extent of activation exerted by the peptides at various Ca2+ concentrations is calculated by dividing enzyme activity measured in the presence and absence of the peptides, taken from A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the extent of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "exerted by the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015264:Exerted [Organism Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "at various Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "calculated by dividing enzyme activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0243102:enzyme activity [Molecular Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Activity [Functional Concept]
   760   C0332849:dividing [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "measured in the presence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "absence of the peptides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "taken from A."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.101: A similar set of experiments was carried out with m-calpain, i.e. with rat 80/21. 

Phrase: "A similar set of experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439787:Out [Spatial Concept]
   833   C0849355:Out [Qualitative Concept]

Phrase: "m-"

Phrase: "calpain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with rat 80/21."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.102: Subdomains A and C exert a qualitatively similar activating effect: at 140M free Ca2+, where enzyme activity is 10% of that at saturating Ca2+ concentrations, the peptides cause an about 5-fold activation of the enzyme (Fig. 4). 

Phrase: "Subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a qualitatively similar activating effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "at 140M free Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "where enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0243102:enzyme activity [Molecular Function]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "10% of that"

Phrase: "at saturating Ca2+ concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an about 5-fold activation of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0014429:Enzyme Activation [Molecular Function]
   744   C1879547:Activation [Activity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.103: Half-maximal peptide concentration is somewhat higher (25M), and the course of activation has a more distinct sigmoidal shape than with -calpain. 

Phrase: "Half-maximal peptide concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   839   C2347813:Maximum Concentration [Quantitative Concept]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "somewhat higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "(25M"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the course of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750729:Course [Temporal Concept]

Phrase: "has"

Phrase: "a more distinct sigmoidal shape than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332479:Shape [Spatial Concept]
   753   C0348078:shape [Qualitative Concept]
   753   C0522512:Shape [Spatial Concept]

Phrase: "with -calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.104: The peptides themselves activate the enzyme about 2-3-fold with a half-effective concentration of 55M. 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "themselves"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the enzyme about 2-3-fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "with a half-effective concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 55M."
Processing 00000000.tx.105: The activation again can be accounted for by an increase in the Ca2+ sensitivity of the enzyme: the half-maximal Ca2+ concentration shifts from 250to 140M at saturating (75M) concentrations of the peptides with no effect on maximal activity (Fig. 5A). 

Phrase: "The activation again"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the Ca2+ sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: ":"

Phrase: "the half-maximal Ca2+ concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   839   C2347813:Maximum Concentration [Quantitative Concept]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "shifts from 250to 140M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]

Phrase: "at saturating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522534:saturating [Phenomenon or Process]

Phrase: "(75M"

Phrase: ")"

Phrase: "concentrations of the peptides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "with no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on maximal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.106: At low Ca2+ concentrations the activation approaches one order of magnitude (Fig. 5B). 

Phrase: "At low Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "one order of magnitude"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.107: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 4.  

Phrase: "4."
Processing 00000000.tx.109: Activation of rat m-calpain by calpastatin subdomains A and C.

Phrase: "Activation of rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "m-"

Phrase: "calpain by calpastatin subdomains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.110: The activity of m-calpain was measured by a fluorescent peptide substrate, LY-AMC, at 140M free Ca2+ concentration as given under "Experimental Procedures." 

Phrase: "The activity of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured by a fluorescent peptide substrate,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0444706:Measured [Qualitative Concept]
   753   C1710236:Substrate [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "LY-AMC,"

Phrase: "at 140M free Ca2+ concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0086045:Concentration [Mental Process]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "given under ""Experimental Procedures."""
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1550718:given [Idea or Concept]
   770   C2700391:procedures [Activity]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.111: To the assay, peptide A () or C () or both A and C () were added at the concentrations indicated. 

Phrase: "To the assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "A ()"

Phrase: "or"

Phrase: "C ()"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "both A"

Phrase: "and"

Phrase: "C ()"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "added at the concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1524062:Added [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.112: The initial rate of substrate consumption was determined and plotted in percentage of the activity measured at saturating (3mM) Ca2+ concentration. 

Phrase: "The initial rate of substrate consumption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205265:Initial [Temporal Concept]
   753   C0871208:Rate [Activity]
   753   C1279901:Initial [Qualitative Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "and"

Phrase: "plotted in percentage of the activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "measured at saturating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0522534:saturating [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(3mM"

Phrase: ")"

Phrase: "Ca2+ concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.113: Data points represent the mean for two to three separate experiments. 

Phrase: "Data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean for two"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "to three separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.114: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.115: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.116: Ca2+ dependence of rat m-calpain activation by calpastatin subdomains A and C.A, the activity of m-calpain was measured by LY-AMC at the free Ca2+ concentrations indicated in the absence () or presence () of 75M peptides A and C.

Phrase: "Ca2+ dependence of rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011546:Dependence [Mental Process]
   770   C0439857:Dependence [Mental or Behavioral Dysfunction]
   770   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "m-"

Phrase: "calpain activation by calpastatin subdomains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "A"

Phrase: "and"

Phrase: "C."

Phrase: "A,"

Phrase: "the activity of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured by LY-AMC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0023634:LY [Geographic Area]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "at the free Ca2+ concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0086045:Concentrations [Mental Process]
   827   C0332296:free [Functional Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "indicated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of 75M peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "A"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.117: The initial rate of substrate consumption in the percentage of the activity measured at saturating (3mM) Ca2+ concentration is given. 

Phrase: "The initial rate of substrate consumption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205265:Initial [Temporal Concept]
   753   C0871208:Rate [Activity]
   753   C1279901:Initial [Qualitative Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]

Phrase: "in the percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "measured at saturating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0522534:saturating [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(3mM"

Phrase: ")"

Phrase: "Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "given."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]
Processing 00000000.tx.118: Free Ca2+ concentration needed for half-maximal activation shifted from 250to 140M by the peptides. 

Phrase: "Free Ca2+ concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0086045:Concentration [Mental Process]
   827   C0332296:free [Functional Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for half-maximal activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0027552:Needed [Qualitative Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0686904:needed [Functional Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1879547:Activation [Activity]
   760   C2825407:Half [Quantitative Concept]

Phrase: "shifted from 250to 140M"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "by the peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.119: B, the extent of activation exerted by the peptides at various Ca2+ concentrations is calculated as given in Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the extent of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "exerted by the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015264:Exerted [Organism Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "at various Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "given in Fig."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]
Processing 00000000.tx.120: 3B for -calpain.  

Phrase: "3B for -calpain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450365:3b [Intellectual Product]
   790   C1706097:3B [Research Activity]
Processing 00000000.tx.121: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The results presented unequivocally demonstrate that peptides corresponding to subdomains A and C of human calpastatin domain I markedly sensitize both - and m-calpain to Ca2+. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "unequivocally"

Phrase: "demonstrate"

Phrase: "that peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "corresponding"

Phrase: "to subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C of human calpastatin domain I markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1547546:C-I [Classification]
   748   C1553033:[c] [Quantitative Concept]

Phrase: "sensitize"

Phrase: "both -"

Phrase: "and"

Phrase: "m-"

Phrase: "calpain to Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.122: At saturating peptide concentrations the peptides lower the Ca2+ concentration needed for half-maximal activity from 4.3to 2.4M for -calpain and from 250to 140M for m-calpain. 

Phrase: "At saturating peptide concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for half-maximal activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0027552:Needed [Qualitative Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0686904:needed [Functional Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "from 4.3to 2.4M"

Phrase: "for -calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and from 250to 140M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for"

Phrase: "m-"

Phrase: "calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.123: Perhaps more significantly, at low Ca2+ concentrations approaching the physiological range both - and m-calpain are activated by an order of magnitude. 

Phrase: "Perhaps more significantly,"

Phrase: "at low Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "approaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:approaching [Spatial Concept]

Phrase: "the physiological range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "both -"

Phrase: "and"

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "activated by an order of magnitude."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1879547:Activated [Activity]
   753   C1882348:Order [Qualitative Concept]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.124: The activation shows a sigmoidal concentration dependence, which indicates cooperativity between binding of the two peptides. 

Phrase: "The activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a sigmoidal concentration dependence,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0011546:Dependence [Mental Process]
   827   C0439857:Dependence [Mental or Behavioral Dysfunction]
   827   C2698668:DEPENDENCE [Regulation or Law]
   755 E C0851827:Dependent [Qualitative Concept]
   755 E C1701901:Dependent [Qualitative Concept]
   755 E C3244310:dependent [Functional Concept]
   727 E C1546937:Dependency [Idea or Concept]

Phrase: "which"

Phrase: "indicates"

Phrase: "cooperativity between binding of the two peptides."
Processing 00000000.tx.125: In structural terms this implies that the conformational change of the two subunits is functionally linked and occurs in a concerted manner. 

Phrase: "In structural terms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "this"

Phrase: "implies"

Phrase: "that"

Phrase: "the conformational change of the two subunits"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0301641:Conformational change [Molecular Function]
   774   C0025320:The change [Physiologic Function]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "functionally"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "occurs in a concerted manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.126: The peptide concentration needed for half-maximal effect is somewhat lower for -calpain (7.5M) than m-calpain (25M), which might be due to the different sensitivity of isoforms, but may also reflect species difference as the peptides are derived from human calpastatin. 

Phrase: "The peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for half-maximal effect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027552:Needed [Qualitative Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0686904:needed [Functional Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "is"

Phrase: "somewhat lower for -calpain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "(7.5M"

Phrase: ")"

Phrase: "than"

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(25M"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "might"

Phrase: "be due to the different sensitivity of isoforms,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0427965:Sensitivity [Finding]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C1705242:Different [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   731   C0332324:Sensitive to [Functional Concept]

Phrase: "but"

Phrase: "may"

Phrase: "also"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "species difference as the peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0178849:species difference [Biologic Function]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "are"

Phrase: "derived from human calpastatin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0086418:Human [Human]
   770   C1413137:CALPASTATIN [Gene or Genome]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.127: Either way, this difference indicates that the development of isoform-specific activator peptides is conceivable. 

Phrase: "Either way,"

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the development of isoform-specific activator peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "is"

Phrase: "conceivable."
Processing 00000000.tx.128: Overall, our observations have three important implications. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "three important implications."
Processing 00000000.tx.129: The first implication relates to the issue of the activation of calpains under physiological Ca2+ concentrations. 

Phrase: "The first implication"

Phrase: "relates to the issue of the activation of calpains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0033213:Issue [Finding]
   742   C0163712:Relate [Organic Chemical]
   742   C1706387:Issue [Intellectual Product]
   742   C1879547:Activation [Activity]
   708   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "under physiological Ca2+ concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.130: As outlined in the introduction, several factors may be involved in lowering the Ca2+ demand of calpains. 

Phrase: "As"

Phrase: "outlined in the introduction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "several factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "involved in lowering"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0441994:lowering [Spatial Concept]
   790   C1314939:Involved [Functional Concept]
   790   C2003888:Lowering [Activity]
   756 E C1548802:Lower [Body Location or Region]

Phrase: "the Ca2+ demand of calpains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441516:Demand [Therapeutic or Preventive Procedure]
   760   C0699784:demand [Idea or Concept]
Processing 00000000.tx.131: Although this issue is not settled yet, it seems that phospholipids (7, 8), nuclear DNA (12), a specific activator protein (11) and autolytic processing of calpain itself (5, 6) may all contribute to shifting the Ca2+ need of calpain toward the physiological range. 

Phrase: "Although"

Phrase: "this issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "settled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1266099:SETTLE [Neoplastic Process]

Phrase: "yet,"

Phrase: "it"

Phrase: "seems"

Phrase: "that phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "nuclear DNA (12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521447:Nuclear [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "a specific activator protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "autolytic processing of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "itself"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: "may"

Phrase: "all"

Phrase: "contribute to shifting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0333051:shifting [Functional Concept]
   790   C1880177:Contribute [Activity]

Phrase: "the Ca2+ need of calpain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027552:Need [Qualitative Concept]
   760   C0686904:need [Functional Concept]

Phrase: "toward the physiological range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.132: Our findings, perhaps paradoxically, bring calpastatin, the specific calpain inhibitor, into this picture. 

Phrase: "Our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "perhaps paradoxically,"

Phrase: "bring"

Phrase: "calpastatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "the specific calpain inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "into this picture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441468:picture [Manufactured Object]
  1000   C0441469:Picture [Manufactured Object]
Processing 00000000.tx.133: In principle, it is possible that calpastatin is fragmented in such a way in vivo that degrades its inhibitory subdomain (B) but leaves activator subdomains A and C more or less intact. 

Phrase: "In principle,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "is"

Phrase: "fragmented in such"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392767:Fragmented [Functional Concept]
   790   C1708096:Fragmented [Qualitative Concept]
   756 E C0332255:fragment [Functional Concept]

Phrase: "a way"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "that"

Phrase: "degrades"

Phrase: "its inhibitory subdomain"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "but"

Phrase: "leaves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242724:Leaves [Plant]

Phrase: "activator subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "less intact."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.134: Under such circumstances activation might override inhibition and calpastatin fragments stimulate calpain. 

Phrase: "Under such circumstances activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "might"

Phrase: "override"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Over-ride [Activity]

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "calpastatin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "stimulate"

Phrase: "calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.135: Calpastatin is very sensitive to proteolysis in vitro (25) and is degraded by caspases (26) and calpain itself (27) in vivo. 

Phrase: "Calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "is"

Phrase: "very sensitive to proteolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "degraded by caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "itself"

Phrase: "(27"

Phrase: ")"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.136: A significant difference in the sequence of calpastatin subdomains A, B, and C suggests that the action of a protease with a trypsin-like specificity may result in such a fragmentation: subdomain B has several Lys and Arg residues making this part of calpastatin sensitive whereas subdomains A and C have only a single N-terminal Lys residue offering limited access to proteolysis. 

Phrase: "A significant difference in the sequence of calpastatin subdomains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the action of a protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "with a trypsin-like specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "may"

Phrase: "result in such"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "a fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332472:Fragmentation [Anatomical Abnormality]
  1000   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: ":"

Phrase: "subdomain B"

Phrase: "has"

Phrase: "several Lys"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Arg residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "this part of calpastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "whereas"

Phrase: "subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "have"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a single N-terminal Lys residue offering limited access to proteolysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0444454:Access [Spatial Concept]
   738   C1554204:access [Idea or Concept]
Processing 00000000.tx.137: The other condition for this mechanism to operate in vivo is that the intracellular concentration of calpastatin be high enough for the peptides to reach a level sufficient for activation. 

Phrase: "The"

Phrase: "other condition for this mechanism to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "operate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242339:operate [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "that"

Phrase: "the intracellular concentration of calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "be"

Phrase: "high enough for the peptides to"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "sufficient for activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.138: Quantitative considerations argue that in some tissues this condition is met. 

Phrase: "Quantitative considerations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]

Phrase: "argue"

Phrase: "that in some tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "this condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "met."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]
Processing 00000000.tx.139: The physiological concentration of calpastatin varies in different tissues from about 0.035to 4.4M (28, 29); 

Phrase: "The physiological concentration of calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "varies in different tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040300:Tissues [Tissue]
   770   C1548673:Varies [Intellectual Product]
   770   C1705242:Different [Qualitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "from about 0.035to 4.4M"

Phrase: "(28,"

Phrase: "29"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.140: as calpastatin consists of four homologous inhibitory domains (cf. Fig. 1), each capable of inhibiting one calpain molecule in a Ca2+-dependent manner (13, 14), the concentration of inhibitory domains, and the potential concentration of activator peptides, is four times higher, i.e. is in the range of 0.14to 17.6M. 

Phrase: "as calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "consists of four homologous inhibitory domains"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205450:Four [Quantitative Concept]
   753   C0332529:CONSIST [Qualitative Concept]
   753   C1334043:Homologous [Gene or Genome]
   753   C3463820:Inhibitory [Activity]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "(cf. Fig. 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0055412:CF 1 [Organic Chemical,Pharmacologic Substance]
   913   C2698722:CF-1 [Mammal]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "each capable of inhibiting one calpain molecule"

Phrase: "in a Ca2+-dependent manner"

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "the concentration of inhibitory domains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "the potential concentration of activator peptides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "four times higher, i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is in the range of 0.14to 17.6M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3171719:6M [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]
Processing 00000000.tx.141: Thus, in certain tissues specific fragmentation of calpastatin may produce the activator peptides in concentrations commensurable with the range used in our studies. 

Phrase: "Thus,"

Phrase: "in certain tissues specific fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332472:Fragmentation [Anatomical Abnormality]
   812   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "of calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "may"

Phrase: "produce"

Phrase: "the activator peptides in concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "commensurable with the range"

Phrase: "used in our studies."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.142: Furthermore, two other considerations support this conclusion in a wider range. 

Phrase: "Furthermore,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other considerations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0518609:considerations [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this conclusion in a wider range."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707478:Conclusion [Idea or Concept]
Processing 00000000.tx.143: First, it seems that calpastatin concentrations at certain locations within the cell is markedly higher than the average values just mentioned. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "that calpastatin concentrations at certain locations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "within the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "markedly higher than the average values just"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "mentioned."
Processing 00000000.tx.144: In an unstimulated cell calpastatin localizes in an aggregated state close to the cell nucleus (30), at local concentrations which significantly exceed the values calculated for homogeneous distribution. 

Phrase: "In an unstimulated cell calpastatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "localizes in an aggregated state"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0332621:Aggregated [Functional Concept]
   760   C0392752:localize [Spatial Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726 E C0205418:Aggregate [Qualitative Concept]

Phrase: "close to the cell nucleus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007610:Cell Nucleus [Cell Component]
           Nucleus
   760   C0007634:Cell [Cell]
   760   C0587267:Close [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "at local concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "which significantly"

Phrase: "exceed"

Phrase: "the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "calculated for homogeneous distribution."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0444686:Calculated [Functional Concept]
   770   C0520511:distribution [Idea or Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1704711:Distribution [Functional Concept]
   770   C1881065:Homogeneous [Qualitative Concept]
Processing 00000000.tx.145: Second, macromolecular crowding caused by the extreme protein concentration in the cytoplasm favors interactions to such an extent that reaction rates and equilibrium constants of interactions may be orders of magnitude higher in vivo than under test tube conditions (31). 

Phrase: "Second, macromolecular crowding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010383:Crowding [Social Behavior]
   827   C0040433:Crowding [Anatomical Abnormality]

Phrase: "caused by the extreme protein concentration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086045:Concentration [Mental Process]
   753   C0205403:Extreme [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "in the cytoplasm favors interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "to such"

Phrase: "an extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "that reaction rates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0678608:reaction rate [Temporal Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "equilibrium constants of interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0678590:equilibrium constant [Natural Phenomenon or Process]
   737   C1547014:*Constant [Quantitative Concept]
   737   C1948059:Constant [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "orders of magnitude higher in vivo"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   753   C3244315:orders [Intellectual Product]
   719 E C1705175:Order [Intellectual Product]
   719 E C1705176:Order [Qualitative Concept]
   719 E C1705177:Order [Classification]
   719 E C1705178:Order [Activity]
   719 E C1882348:Order [Qualitative Concept]

Phrase: "than"

Phrase: "under test tube conditions"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   913   C0449910:Test conditions [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0183884:Test tube [Medical Device]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: Because of this mechanism, fragments corresponding to the same amount of calpastatin subdomains A and C may give a much higher effective concentration in the cell than in dilute solution in the test tube and activate calpain at concentrations significantly lower than the values reported in this work. 

Phrase: "Because of this mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to the same amount of calpastatin subdomains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0054534:calpastatin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0445247:Same [Qualitative Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1413137:CALPASTATIN [Gene or Genome]

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: "may"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a much higher effective concentration in the cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "than"

Phrase: "in dilute solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "in the test tube"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0183884:Test tube [Medical Device]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0175730:Tube [Medical Device]
   861   C0392366:test [Intellectual Product]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "calpain at concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "significantly lower than the values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "reported in this work."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0043227:Work [Occupational Activity]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.147: The second general implication of our work is related to previous efforts at characterizing the physiological function of calpains. 

Phrase: "The second general implication of our work"

Phrase: "is"

Phrase: "related to previous efforts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205156:Previous [Temporal Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1552607:previous [Temporal Concept]
   737   C0015264:Effort [Organism Function]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "at characterizing"

Phrase: "the physiological function of calpains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.148: It is known from knockout experiments that calpains play an essential role as deletion of the ubiquitous small subunit is lethal in mice (32). 

Phrase: "It"

Phrase: "is"

Phrase: "known from knockout experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205309:Known [Qualitative Concept]
   770   C0560617:knock out [Injury or Poisoning]
   770   C0681814:Experiments [Research Activity]
   770   C1522225:Knock-out [Experimental Model of Disease]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "that calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an essential role as deletion of the ubiquitous small subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "lethal in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3151529:Lethal [Finding]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.149: The role of various calpain forms has been extensively studied, almost invariably by the application of calpain inhibitors. 

Phrase: "The role of various calpain forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "almost invariably by the application of calpain inhibitors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0185125:Application [Health Care Activity]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]
   711 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.150: From such studies we know that calpain(s) play a regulatory role in basic cellular processes such as the cell cycle (33), cell motility (34), cell spreading (35), apoptosis (36), and many more. 

Phrase: "From such"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "know"

Phrase: "that calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a regulatory role in basic cellular processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "such as the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "cell motility"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007608:cell motility [Cell Function]
           Motility
   861   C0678835:Motility [Laboratory or Test Result]
   861   C1510470:Motility [Organism Function]
   789 E C1979933:Motile [Finding]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "spreading"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332261:Spreading [Qualitative Concept]
   966 E C1947932:Spread [Activity]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "many more."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]
Processing 00000000.tx.151: The inhibitors, however, lack strict specificity. 

Phrase: "The inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "however,"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "strict specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.152: They may react with the proteosome, lysosomal proteinases, or even non-proteolytic enzymes (37, 38). 

Phrase: "They"

Phrase: "may"

Phrase: "react with the proteosome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0208355:Proteosome [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lysosomal proteinases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "or"

Phrase: "even non-proteolytic enzymes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030940:Proteolytic Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1947941:Proteolytic Enzyme [Enzyme]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.153: These findings have prompted the development of strictly specific calpain inhibitors (39) or the use of a cell-permeable variety of calpastatin subdomain B for cell biological studies. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "the development of strictly specific calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "(39"

Phrase: ")"

Phrase: "or"

Phrase: "the use of a cell-permeable variety of calpastatin subdomain B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1524063:Use of [Functional Concept]
   738   C0042153:use [Functional Concept]
   738   C0457083:Use [Functional Concept]
   738   C1947944:Use [Intellectual Product]

Phrase: "for cell biological studies."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0007634:Cell [Cell]
   827   C0205460:biological [Qualitative Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.154: In general, the results with calpain inhibitors cannot always be unequivocally associated with the action of calpain. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the results with calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "cannot"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "be"

Phrase: "unequivocally"

Phrase: "associated with the action of calpain."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.155: Thus, it is desirable to develop activators for calpain based on our observations with subdomains A and C.As these peptides are highly charged, both subdomains have to be fused with "carrier" peptides that make other substances membrane-permeable. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "desirable to"

Phrase: "develop"

Phrase: "activators for calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   841   C0915424:calpain activator [Amino Acid, Peptide, or Protein]

Phrase: "based on our observations"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3244290:observations [Functional Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "with subdomains"

Phrase: "A"

Phrase: "and"

Phrase: "C.As these peptides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0006558:c peptides [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C1553033:[c] [Quantitative Concept]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: ","

Phrase: "both subdomains"

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "fused with ""carrier"" peptides"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0007294:Carrier [Finding]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0560175:Carrier [Finding]
   770   C0699952:Fused [Functional Concept]
   770   C1706209:Carrier [Medical Device]
   770   C3273162:Carrier [Intellectual Product]
   737 E C1414861:FUSE [Gene or Genome]
   737 E C1708111:Fuse [Manufactured Object]

Phrase: "that"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "other substances membrane-permeable."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   865   C0007605:membrane permeabilities [Cell Function]
   827   C0205326:Permeable [Functional Concept]
   755 E C0031164:Permeabilities [Natural Phenomenon or Process]
Processing 00000000.tx.156: The development of such constructs, which will probably complement the use of calpain inhibitors in further analysis of calpain function, is under way.2 The third implication worth considering is related to the pathological role of calpain. 

Phrase: "The development of such constructs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "which"

Phrase: "will"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "complement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the use of calpain inhibitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "in further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of calpain function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "under way.2"

Phrase: "The third implication worth considering"

Phrase: "is"

Phrase: "related to the pathological role of calpain."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0035820:Role [Social Behavior]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1521733:Pathological [Functional Concept]
   748   C1705810:Role [Conceptual Entity]
   714 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.157: Overactivation of calpain seems to be important in a range of disorders (37, 40); 

Phrase: "Overactivation of calpain"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in a range of disorders"

Phrase: "(37,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.158: more recent findings, however, point to the link of diminished activity and the development of pathological states. 

Phrase: "more recent findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "however,"

Phrase: "point to the link of diminished activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "the development of pathological states."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.159: Positional cloning in patients with limb girdle muscular dystrophy 2A linked the gene of calpain 3(p94) with this disease (41). 

Phrase: "Positional cloning in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1656250:positional cloning [Research Activity]
   770   C0009015:Cloning [Research Activity]

Phrase: "with limb girdle muscular dystrophy 2A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0686353:Muscular Dystrophy, Limb-Girdle [Disease or Syndrome]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "the gene of calpain 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]

Phrase: "(p94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1259929:p94 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413113:p94 [Gene or Genome]

Phrase: ")"

Phrase: "with this disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.160: Later studies revealed that disease is associated with mutations in this gene, which invariably leads to a partial or complete loss of enzyme activity (42). 

Phrase: "Later studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in this gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "which invariably"

Phrase: "leads to a partial"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0728938:Partial [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1550516:partial [Idea or Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "complete loss of enzyme activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.161: In a similar approach, diabetes mellitus type 2,which accounts for about 90% of the incidence of diabetes, was linked to the gene of calpain 10(43); 

Phrase: "In a similar approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "diabetes mellitus type 2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011860:Diabetes mellitus type 2 [Disease or Syndrome]
           Diabetes Type 2
   875   C1320657:Diabetes type [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "accounts for about 90% of the incidence of diabetes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0021149:Incidence [Quantitative Concept]
   742   C0220856:incidence [Functional Concept]
   742   C0439083:>90 [Quantitative Concept]
   742   C0439087:<90 [Quantitative Concept]
   742   C1551359:account [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]

Phrase: "was"

Phrase: "linked to the gene of calpain 10"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413110:CALPAIN 10 [Gene or Genome]
   774   C0314613:Linked gene [Genetic Function]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017337:Gene [Gene or Genome]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "(43"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.162: a single-nucleotide polymorphism within one intron of the gene is associated with a significantly reduced mRNA level (44). 

Phrase: "a single-nucleotide polymorphism within one intron of the gene"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032529:Polymorphism [Genetic Function]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with a significantly reduced mRNA level"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.163: Thus, the enzyme in this case is fully active, but it is expressed at a lower level. 

Phrase: "Thus,"

Phrase: "the enzyme in this case"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "is"

Phrase: "fully active,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "expressed at a lower level."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441889:Level [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.164: The two diseases, and possibly others, have in common a diminution in calpain activity; 

Phrase: "The two diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "possibly others,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]

Phrase: "have in common"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205214:Common [Quantitative Concept]
   790   C1522138:Common [Functional Concept]
   790   C3154893:Have [Idea or Concept]
   790   C3245511:common [Intellectual Product]
   790   C3539897:Have [Qualitative Concept]

Phrase: "a diminution in calpain activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332511:Diminution [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.165: apparently, drugs that could boost activity might be beneficial.  

Phrase: "apparently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "could"

Phrase: "boost"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511253:Boost [Functional Concept]
  1000   C1874596:BOOST [Food]

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "might"

Phrase: "be"

Phrase: "beneficial."
Processing 00000000.tx.166: ACKNOWLEDGEMENTS We thank Prof. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.167: J.S.Elce (Queen's University, Kingston, Ontario, Canada) for kindly providing the expression construct of rat m-calpain (80/21).  

Phrase: "J.S.Elce"

Phrase: "(Queen's University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kingston,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the expression construct of rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "m-"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(80/21"

Phrase: ")."
Processing 00000000.tx.168: FOOTNOTES * This work was supported by Grants T 17633,T 22069,T 030841,and T 32360from the Hungarian Scientific Research Fund (OTKA) and AKP 98-13 3,3from the Hungarian Academy of Sciences.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grants T 17633,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0018173:Grants [Quantitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "T 22069,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "T 030841,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "T 32360from"

Phrase: "the Hungarian Scientific Research Fund"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "(OTKA"

Phrase: ")"

Phrase: "and"

Phrase: "AKP 98-13 3,"

Phrase: "3from"

Phrase: "the Hungarian Academy of Sciences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000876:Academy [Organization]
Processing 00000000.tx.169: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.170: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.171: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.172: Supported by a Bolyai Jnos Scholarship. 

Phrase: "Supported by a Bolyai Jnos Scholarship."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0036365:scholarship [Idea or Concept]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]
Processing 00000000.tx.173: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.174: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.175: 361-466-5633; 

Phrase: "361-466-5633"

Phrase: ";"
Processing 00000000.tx.176: Fax: 361-466-5465; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "361-466-5465"

Phrase: ";"
Processing 00000000.tx.177: E-mail: tompa@enzim.hu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "tompa@enzim.hu."
Processing 00000000.tx.178: Published, JBC Papers in Press, January 23,2002,DOI 10.1074/jbc.C100700200 2 P. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "January 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.C100700200 2 P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   893   C0048408:DOI-P [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.179: Tompa and P.

Phrase: "Tompa"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.180: Friedrich (December 10,2001) Hungarian Patent P0105289.  

Phrase: "Friedrich"

Phrase: "(December 10,"

Phrase: "2001"

Phrase: ")"

Phrase: "Hungarian Patent P0105289."
Processing 00000000.tx.181: ABBREVIATIONS The abbreviations used are: Boc, t-butoxycarbonyl; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "Boc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1826625:BOC [Gene or Genome]

Phrase: "t-butoxycarbonyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.182: LY-AMC, N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin.  

Phrase: "LY-AMC,"

Phrase: "N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin."
Processing 00000000.tx.183: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.184: Sorimachi, H., Ishiura, S., and Suzuki, K. 

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ishiura,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.185: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.186: J. 

Phrase: "J."
Processing 00000000.tx.187: 328, 721-732[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "328,"

Phrase: "721-732"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.188: Sorimachi, H., and Suzuki, K. 

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.189: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.190: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.191: (Tokyo) 129, 653-664[Abstract] 3. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "129,"

Phrase: "653-664"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.192: Hosfield, C. 

Phrase: "Hosfield,"

Phrase: "C."
Processing 00000000.tx.193: M., Elce, J. 

Phrase: "M."

Phrase: ","

Phrase: "Elce,"

Phrase: "J."
Processing 00000000.tx.194: S., Davies, P. 

Phrase: "S."

Phrase: ","

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.195: L., and Jia, Z. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Jia,"

Phrase: "Z."
Processing 00000000.tx.196: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.197: 18, 6880-6889[Abstract/Free FullText] 4. 

Phrase: "18,"

Phrase: "6880-6889"

Phrase: "[Abstract/Free FullText"

Phrase: "] 4."
Processing 00000000.tx.198: Strobl, S., Fernandez-Catalan, C., Braun, M., Huber, R., Masumoto, H., Nakagawa, K., Irie, A., Sorimachi, H., Bourenkow, G., Bartunik, H., Suzuki, K., and Bode, W. 

Phrase: "Strobl,"

Phrase: "S."

Phrase: ","

Phrase: "Fernandez-Catalan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Braun,"

Phrase: "M."

Phrase: ","

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Irie,"

Phrase: "A.,"

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bourenkow,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bartunik,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Bode"

Phrase: ","

Phrase: "W."
Processing 00000000.tx.199: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.200: Natl. 

Phrase: "Natl."
Processing 00000000.tx.201: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.202: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.203: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.204: 97, 588-592[Abstract/Free FullText] 5. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "588-592"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.205: Baki, A., Tompa, P., Alexa, A., Molnr, O., and Friedrich, P. 

Phrase: "Baki,"

Phrase: "A.,"

Phrase: "Tompa,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Alexa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1071616:Alexa [Plant]

Phrase: "A.,"

Phrase: "Molnr,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Friedrich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.206: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.207: J. 

Phrase: "J."
Processing 00000000.tx.208: 318, 897-901[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "318,"

Phrase: "897-901"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.209: Suzuki, K., Tsuji, S., Ishiura, S., Kimura, Y., Kubota, S., and Imahori, K. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "Ishiura,"

Phrase: "S."

Phrase: ","

Phrase: "Kimura,"

Phrase: "Y.,"

Phrase: "Kubota,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.210: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.211: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.212: (Tokyo) 90, 1787-1793[Abstract] 7. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1787-1793"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 7."
Processing 00000000.tx.213: Saido, T. 

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.214: C., Shibata, M., Takenawa, T., Murofushi, H., and Suzuki, K. 

Phrase: "C., Shibata,"

Phrase: "M."

Phrase: ","

Phrase: "Takenawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murofushi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.215: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.216: Biol. 

Phrase: "Biol."
Processing 00000000.tx.217: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.218: 267, 24585-24590[Abstract/Free FullText] 8. 

Phrase: "267,"

Phrase: "24585-24590"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.219: Tompa, P., Emori, Y., Sorimachi, H., Suzuki, K., and Friedrich, P. 

Phrase: "Tompa,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Emori,"

Phrase: "Y.,"

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Friedrich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.220: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.221: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.222: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.223: Commun. 

Phrase: "Commun."
Processing 00000000.tx.224: 280, 1333-1339[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "280,"

Phrase: "1333-1339"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.225: Michetti, M., Salamino, F., Tedesco, I., Averna, M., Minafra, R., Melloni, E., and Pontremoli, S. 

Phrase: "Michetti,"

Phrase: "M."

Phrase: ","

Phrase: "Salamino,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tedesco,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Averna,"

Phrase: "M."

Phrase: ","

Phrase: "Minafra,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Melloni,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Pontremoli,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.226: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.227: 392, 11-15[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "392,"

Phrase: "11-15"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.228: Suzuki, K., and Sorimachi, H. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sorimachi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.229: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.230: 433, 1-4[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "433,"

Phrase: "1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.231: Melloni, E., Michetti, M., Salamino, F., Sparatore, B., and Pontremoli, S. 

Phrase: "Melloni,"

Phrase: "E.,"

Phrase: "Michetti,"

Phrase: "M."

Phrase: ","

Phrase: "Salamino,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sparatore,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pontremoli,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.232: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.233: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.234: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.235: Commun. 

Phrase: "Commun."
Processing 00000000.tx.236: 249, 583-588[CrossRef][Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "249,"

Phrase: "583-588"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.237: Mellgren, R. 

Phrase: "Mellgren,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.238: L., Song, K., and Mericle, M. 

Phrase: "L., Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872005:Song [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mericle,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.239: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.240: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.241: Biol. 

Phrase: "Biol."
Processing 00000000.tx.242: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.243: 268, 653-657[Abstract/Free FullText] 13. 

Phrase: "268,"

Phrase: "653-657"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.244: Maki, M., Takano, E., Mori, H., Sato, A., Murachi, T., and Hatanaka, M. 

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sato,"

Phrase: "A.,"

Phrase: "Murachi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hatanaka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.245: (1987) FEBS Lett. 

Phrase: "(1987"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.246: 223, 174-180[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "223,"

Phrase: "174-180"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.247: Emori, Y., Kawasaki, H., Imajoh, S., Minami, Y., and Suzuki, K. 

Phrase: "Emori,"

Phrase: "Y.,"

Phrase: "Kawasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Imajoh,"

Phrase: "S."

Phrase: ","

Phrase: "Minami,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.248: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.249: Biol. 

Phrase: "Biol."
Processing 00000000.tx.250: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.251: 263, 2364-2370[Abstract/Free FullText] 15. 

Phrase: "263,"

Phrase: "2364-2370"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.252: Imajoh, S., and Suzuki, K. 

Phrase: "Imajoh,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.253: (1985) FEBS Lett. 

Phrase: "(1985"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.254: 187, 47-50[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "187,"

Phrase: "47-50"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.255: Nishimura, T., and Goll, D. 

Phrase: "Nishimura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Goll,"

Phrase: "D."
Processing 00000000.tx.256: E. 

Phrase: "E."
Processing 00000000.tx.257: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.258: Biol. 

Phrase: "Biol."
Processing 00000000.tx.259: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.260: 266, 11842-11850[Abstract/Free FullText] 17. 

Phrase: "266,"

Phrase: "11842-11850"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.261: Yang, H. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.262: Q., Ma, H., Takano, E., Hatanaka, M., and Maki, M. 

Phrase: "Q., Ma,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Hatanaka,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Maki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.264: Biol. 

Phrase: "Biol."
Processing 00000000.tx.265: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.266: 269, 18977-18984[Abstract/Free FullText] 18. 

Phrase: "269,"

Phrase: "18977-18984"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.267: Kapprell, H. 

Phrase: "Kapprell,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.268: P., and Goll, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Goll,"

Phrase: "D."
Processing 00000000.tx.269: E. 

Phrase: "E."
Processing 00000000.tx.270: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.271: Biol. 

Phrase: "Biol."
Processing 00000000.tx.272: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.273: 264, 17888-17896[Abstract/Free FullText] 19. 

Phrase: "264,"

Phrase: "17888-17896"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.274: Maki, M., Bagci, H., Hamaguchi, K., Ueda, M., Murachi, T., and Hatanaka, M. 

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Bagci,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hamaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "M."

Phrase: ","

Phrase: "Murachi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hatanaka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.276: Biol. 

Phrase: "Biol."
Processing 00000000.tx.277: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.278: 264, 18866-18869[Abstract/Free FullText] 20. 

Phrase: "264,"

Phrase: "18866-18869"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.279: Ma, H., Yang, H. 

Phrase: "Ma,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.280: Q., Takano, E., Lee, W. 

Phrase: "Q., Takano,"

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "W."
Processing 00000000.tx.281: J., Hatanaka, M., and Maki, M. 

Phrase: "J.,"

Phrase: "Hatanaka,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Maki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.282: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.283: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.284: (Tokyo) 113, 591-599[Abstract] 21. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "113,"

Phrase: "591-599"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 21."
Processing 00000000.tx.285: Takano, E., Ma, H., Yang, H. 

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Ma,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.286: Q., Maki, M., and Hatanaka, M. 

Phrase: "Q., Maki,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hatanaka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: (1995) FEBS Lett. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.288: 362, 93-97[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "362,"

Phrase: "93-97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.289: Ma, H., Yang, H. 

Phrase: "Ma,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.290: Q., Takano, E., Hatanaka, M., and Maki, M. 

Phrase: "Q., Takano,"

Phrase: "E.,"

Phrase: "Hatanaka,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Maki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.292: Biol. 

Phrase: "Biol."
Processing 00000000.tx.293: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.294: 269, 24430-24436[Abstract/Free FullText] 23. 

Phrase: "269,"

Phrase: "24430-24436"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.295: Maki, M., Takano, E., Osawa, T., Ooi, T., Murachi, T., and Hatanaka, M. 

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Osawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ooi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murachi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hatanaka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.296: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.297: Biol. 

Phrase: "Biol."
Processing 00000000.tx.298: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.299: 263, 10254-10261[Abstract/Free FullText] 24. 

Phrase: "263,"

Phrase: "10254-10261"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.300: Elce, J. 

Phrase: "Elce,"

Phrase: "J."
Processing 00000000.tx.301: S., Hegadorn, C., Gauthier, S., Vince, J. 

Phrase: "S."

Phrase: ","

Phrase: "Hegadorn,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gauthier,"

Phrase: "S."

Phrase: ","

Phrase: "Vince,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0885123:vince [Organic Chemical,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.302: W., and Davies, P. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.303: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.304: (1995) Protein Eng. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Protein Eng."
Processing 00000000.tx.305: 8, 843-848[Abstract] 25. 

Phrase: "8,"

Phrase: "843-848"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25."
Processing 00000000.tx.306: Takano, E., Maki, M., Mori, H., Hatanaka, M., Marti, T., Titani, K., Kannagi, R., Ooi, T., and Murachi, T. 

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hatanaka,"

Phrase: "M."

Phrase: ","

Phrase: "Marti,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Titani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kannagi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ooi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Murachi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.307: (1988) Biochemistry 27, 1964-1972[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Biochemistry 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1964-1972"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.308: Kato, M., Nonaka, T., Maki, M., Kikuchi, H., and Imajoh-Ohmi, S. 

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "M."

Phrase: ","

Phrase: "Nonaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Kikuchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Imajoh-Ohmi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.309: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.310: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.311: (Tokyo) 127, 297-305[Abstract] 27. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "127,"

Phrase: "297-305"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 27."
Processing 00000000.tx.312: De Tullio, R., Averna, M., Salamino, F., Pontremoli, S., and Melloni, E. 

Phrase: "De Tullio,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Averna,"

Phrase: "M."

Phrase: ","

Phrase: "Salamino,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pontremoli,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Melloni,"

Phrase: "E."
Processing 00000000.tx.313: (2000) FEBS Lett. 

Phrase: "(2000"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.314: 475, 17-21[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "475,"

Phrase: "17-21"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.315: Otsuka, Y., and Goll, D. 

Phrase: "Otsuka,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Goll,"

Phrase: "D."
Processing 00000000.tx.316: E. 

Phrase: "E."
Processing 00000000.tx.317: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.318: Biol. 

Phrase: "Biol."
Processing 00000000.tx.319: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.320: 262, 5839-5851[Abstract/Free FullText] 29. 

Phrase: "262,"

Phrase: "5839-5851"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.321: Thompson, V. 

Phrase: "Thompson,"

Phrase: "V."
Processing 00000000.tx.322: F., and Goll, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Goll,"

Phrase: "D."
Processing 00000000.tx.323: E. 

Phrase: "E."
Processing 00000000.tx.324: (2000) in Calpain Methods and Protocols (Elce, J. S., ed), Vol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "in Calpain Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "(Elce,"

Phrase: "J."

Phrase: "S."

Phrase: ","

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.325: 144 , pp. 

Phrase: "144 ,"

Phrase: "pp."
Processing 00000000.tx.326: 3-16, Humana Press, Totowa, NJ 30. 

Phrase: "3-16,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "Humana Press,"

Phrase: "Totowa,"

Phrase: "NJ 30."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]
Processing 00000000.tx.327: Tullio, R. 

Phrase: "Tullio,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: D., Passalacqua, M., Averna, M., Salamino, F., Melloni, E., and Pontremoli, S. 

Phrase: "D."

Phrase: ","

Phrase: "Passalacqua,"

Phrase: "M."

Phrase: ","

Phrase: "Averna,"

Phrase: "M."

Phrase: ","

Phrase: "Salamino,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Melloni,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Pontremoli,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.329: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.330: J. 

Phrase: "J."
Processing 00000000.tx.331: 343, 467-472[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "343,"

Phrase: "467-472"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.332: Ellis, R. 

Phrase: "Ellis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.333: J. 

Phrase: "J."
Processing 00000000.tx.334: (2001) Trends Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.335: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.336: 26, 597-604[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "26,"

Phrase: "597-604"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.337: Arthur, J. 

Phrase: "Arthur,"

Phrase: "J."
Processing 00000000.tx.338: S., Elce, J. 

Phrase: "S."

Phrase: ","

Phrase: "Elce,"

Phrase: "J."
Processing 00000000.tx.339: S., Hegadorn, C., Williams, K., and Greer, P. 

Phrase: "S."

Phrase: ","

Phrase: "Hegadorn,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Williams,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Greer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.340: A. 

Phrase: "A."
Processing 00000000.tx.341: (2000) Mol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.342: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.343: Biol. 

Phrase: "Biol."
Processing 00000000.tx.344: 20, 4474-4481[Abstract/Free FullText] 33. 

Phrase: "20,"

Phrase: "4474-4481"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.345: Mellgren, R. 

Phrase: "Mellgren,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.347: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.348: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.349: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.350: Commun. 

Phrase: "Commun."
Processing 00000000.tx.351: 236, 555-558[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "236,"

Phrase: "555-558"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.352: Glading, A., Chang, P., Lauffenburger, D. 

Phrase: "Glading,"

Phrase: "A.,"

Phrase: "Chang,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lauffenburger,"

Phrase: "D."
Processing 00000000.tx.353: A., and Wells, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "A."
Processing 00000000.tx.354: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.355: Biol. 

Phrase: "Biol."
Processing 00000000.tx.356: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.357: 275, 2390-2398[Abstract/Free FullText] 35. 

Phrase: "275,"

Phrase: "2390-2398"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.358: Croce, K., Flaumenhaft, R., Rivers, M., Furie, B., Furie, B. 

Phrase: "Croce,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Flaumenhaft,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rivers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337050:Rivers [Natural Phenomenon or Process]

Phrase: "M."

Phrase: ","

Phrase: "Furie,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Furie,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.359: C., Herman, I. 

Phrase: "C., Herman,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.360: M., and Potter, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.361: A. 

Phrase: "A."
Processing 00000000.tx.362: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.363: Biol. 

Phrase: "Biol."
Processing 00000000.tx.364: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.365: 274, 36321-36327[Abstract/Free FullText] 36. 

Phrase: "274,"

Phrase: "36321-36327"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.366: Blomgren, K., Zhu, C., Wang, X., Karlsson, J. 

Phrase: "Blomgren,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Karlsson,"

Phrase: "J."
Processing 00000000.tx.367: O., Leverin, A. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Leverin,"

Phrase: "A."
Processing 00000000.tx.368: L., Bahr, B. 

Phrase: "L., Bahr,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.369: A., Mallard, C., and Hagberg, H. 

Phrase: "A.,"

Phrase: "Mallard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Hagberg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.370: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.371: Biol. 

Phrase: "Biol."
Processing 00000000.tx.372: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.373: 276, 10191-10198[Abstract/Free FullText] 37. 

Phrase: "276,"

Phrase: "10191-10198"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.374: Wang, K. 

Phrase: "Wang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.375: K., and Yuen, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yuen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.376: W. 

Phrase: "W."
Processing 00000000.tx.377: (1994) Trends Pharmacol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.378: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.379: 15, 412-419[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "15,"

Phrase: "412-419"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.380: Donkor, I. 

Phrase: "Donkor,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.381: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.382: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.383: Med. 

Phrase: "Med."
Processing 00000000.tx.384: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.385: 7, 1171-1188[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "7,"

Phrase: "1171-1188"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.386: Wang, K. 

Phrase: "Wang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.387: K., Nath, R., Posner, A., Raser, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538040:NATH [Gene or Genome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Posner,"

Phrase: "A.,"

Phrase: "Raser,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.388: J., Buroker-Kilgore, M., Hajimohammadreza, I., Probert, A. 

Phrase: "J.,"

Phrase: "Buroker-Kilgore,"

Phrase: "M."

Phrase: ","

Phrase: "Hajimohammadreza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Probert,"

Phrase: "A."
Processing 00000000.tx.389: W., Jr., Marcoux, F. 

Phrase: "W., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Marcoux,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.390: W., Ye, Q., Takano, E., Hatanaka, M., Maki, M., Caner, H., Collins, J. 

Phrase: "W., Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "Q.,"

Phrase: "Takano,"

Phrase: "E.,"

Phrase: "Hatanaka,"

Phrase: "M."

Phrase: ","

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Caner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Collins,"

Phrase: "J."
Processing 00000000.tx.391: L., Fergus, A., Lee, K. 

Phrase: "L., Fergus,"

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.392: S., Lunney, E. 

Phrase: "S."

Phrase: ","

Phrase: "Lunney,"

Phrase: "E."
Processing 00000000.tx.393: A., Hays, S. 

Phrase: "A.,"

Phrase: "Hays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440666:Hay [Immunologic Factor]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.394: J., and Yuen, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Yuen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.395: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.396: Natl. 

Phrase: "Natl."
Processing 00000000.tx.397: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.398: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.399: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.400: 93, 6687-6692[Abstract/Free FullText] 40. 

Phrase: "93,"

Phrase: "6687-6692"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.401: Wang, K. 

Phrase: "Wang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.402: K., and Yuen, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yuen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.403: W. 

Phrase: "W."
Processing 00000000.tx.404: (1997) Adv. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.405: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.406: 37, 117-152[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "37,"

Phrase: "117-152"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.407: Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al.. 

Phrase: "Richard,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Broux,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Allamand,"

Phrase: "V.,"

Phrase: "Fougerousse,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Chiannilkulchai,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bourg,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brenguier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Devaud,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pasturaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roudaut,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "et al.."
Processing 00000000.tx.408: (1995) Cell 81, 27-40[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 81,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "27-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.409: Ono, Y., Shimada, H., Sorimachi, H., Richard, I., Saido, T. 

Phrase: "Ono,"

Phrase: "Y.,"

Phrase: "Shimada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Richard,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: C., Beckmann, J. 

Phrase: "C., Beckmann,"

Phrase: "J."
Processing 00000000.tx.411: S., Ishiura, S., and Suzuki, K. 

Phrase: "S."

Phrase: ","

Phrase: "Ishiura,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.412: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.413: Biol. 

Phrase: "Biol."
Processing 00000000.tx.414: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.415: 273, 17073-17078[Abstract/Free FullText] 43. 

Phrase: "273,"

Phrase: "17073-17078"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.416: Horikawa, Y., Oda, N., Cox, N. 

Phrase: "Horikawa,"

Phrase: "Y.,"

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cox,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.417: J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. 

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Orho-Melander,"

Phrase: "M."

Phrase: ","

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Hinokio,"

Phrase: "Y.,"

Phrase: "Lindner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.418: H., Mashima, H., Schwarz, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mashima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: E., del Bosque-Plata, L., Oda, Y., Yoshiuchi, I., Colilla, S., Polonsky, K. 

Phrase: "E.,"

Phrase: "del Bosque-Plata,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "Y.,"

Phrase: "Yoshiuchi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla,"

Phrase: "S."

Phrase: ","

Phrase: "Polonsky,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.420: S., Wei, S., Concannon, P., Iwasaki, N., Schulze, J., Baier, L. 

Phrase: "S."

Phrase: ","

Phrase: "Wei,"

Phrase: "S."

Phrase: ","

Phrase: "Concannon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Iwasaki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Schulze,"

Phrase: "J.,"

Phrase: "Baier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.421: J., Bogardus, C., Groop, L., Boerwinkle, E., Hanis, C. 

Phrase: "J.,"

Phrase: "Bogardus,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Groop,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Boerwinkle,"

Phrase: "E.,"

Phrase: "Hanis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551922:Hanis [Language]

Phrase: "C."
Processing 00000000.tx.422: L., and Bell, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.423: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.424: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.425: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.426: 26, 163-175[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "26,"

Phrase: "163-175"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.427: Baier, L. 

Phrase: "Baier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.428: J., Permana, P. 

Phrase: "J.,"

Phrase: "Permana,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: A., Yang, X., Pratley, R. 

Phrase: "A.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "X.,"

Phrase: "Pratley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.430: E., Hanson, R. 

Phrase: "E.,"

Phrase: "Hanson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.431: L., Shen, G. 

Phrase: "L., Shen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.432: Q., Mott, D., Knowler, W. 

Phrase: "Q., Mott,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265234:MOTT [Bacterium]

Phrase: "D."

Phrase: ","

Phrase: "Knowler,"

Phrase: "W."
Processing 00000000.tx.433: C., Cox, N. 

Phrase: "C., Cox,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.434: J., Horikawa, Y., Oda, N., Bell, G. 

Phrase: "J.,"

Phrase: "Horikawa,"

Phrase: "Y.,"

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.435: I., and Bogardus, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bogardus,"

Phrase: "C."
Processing 00000000.tx.436: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.438: Invest. 

Phrase: "Invest."
Processing 00000000.tx.439: 106, R69-R73[Abstract/Free FullText] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "106,"

Phrase: "R69-R73"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

